Dr. Harsh Atul Hirani
M.B.B.S. | F.Diab (Dr. Mohan’s, Chennai) | PG Diploma – Medical Law, Policy & Ethics (NLU, Gandhinagar)
ACAI (ABAIM, USA) | NCAM (MIT, USA)
” Serve humanity in the field of Diabetology by developing state-of-the-art healthcare systems for comprehensive diabetes care and driving the change in preventive management of diabetes complications through innovative technology integration. “
About Dr. Harsh
Dr. Harsh Atul Hirani is a Hyderabad-based Diabetologist, healthcare innovator, and internationally recognized speaker at the intersection of clinical medicine, artificial intelligence, and medical law. His work spans advanced diabetes management, CGM technology, AI-driven care models, and regulatory ethics — making him one of India’s most versatile clinician-technologists in the field.
A winner of the Torrent Young Scholar Award 2019 as Best Orator Diabetologist in India, Dr. Harsh holds an Advanced Certification in AI in Medicine (ABAIM, USA – 89.19%), a PG Diploma in Medical Law, Ethics & Policymaking (NLU, Gandhinagar), and a No Code AI & ML certification from MIT, USA. He is also a GOLD Level Global Trainer with the Time in Range Academy, Park Nicollet International Diabetes Center, Minnesota.
As Co-Founder of DocYantra Pvt. Ltd. (NASSCOM-incubated AI-in-Healthcare solutions company), the SHIFT Foundation (Synapse for Healthcare Innovation & Future Technology), and the Metabolic Research Foundation, Dr. Harsh is actively building the next generation of AI-driven clinical tools for India and beyond. He also served as Joint Secretary for the Diabetes India 2026 International Conference, Hyderabad.
Healthcare Professionals Trained
BNI Members Coached across 20+ Chapters
AI & Healthcare Technology Training
International Training Impact
Current Roles & Appointments
Consultant Diabetologist — Multi-Centre Practice
Verara Polyclinic · Lifecare Centre for Diabetes (Ramanthapur) · Lifestyle Clinic by Dr. Rajender (Banjara Hills) · Dr. KVNN’s Advanced Wound Healing Clinics (Weekly)
Co-Founder & Director — DocYantra Pvt. Ltd.
NASSCOM-CoE & GLIC incubated AI-in-Healthcare company building cutting-edge diagnostic, monitoring, and clinical decision tools.
Co-Founder — SHIFT Foundation
Driving research, education, and innovation at the convergence of healthcare and emerging technology.
Joint Secretary — Diabetes India 2026, International Conference
Director Consultant & Regional Trainer — BNI Hyderabad
Youngest Business Coach in BNI Hyderabad Region. Mentored 20+ chapters; coached 1,200+ BNI members including CEOs, CFOs, and MDs; delivered 150+ hours of business coaching.
Subeditor — International Journal of Diabetes in Developing Countries (IJDDC)
Startups Mentor — Sanjeevan Healthcare Accelerator
Core Competencies
- Advanced Diabetes Management
- CGM & Time-in-Range
- AI in Medicine (ABAIM · MIT)
- Healthcare AI Strategy
- Medical Law, Ethics & Policy
- Diabetes Technology & Therapeutics
- Medical Research & Peer Review
- International Keynote Speaking
- Business Coaching & Leadership
Education & Certifications
Advanced Certification in AI in Medicine (ACAI) — Score: 89.19% Advanced Level
PG Diploma in Medical Law, Ethics & Policymaking
No Code AI Mastery (NCAM)
Medical Practice Management in New Media Era
GOLD Level Trainer Certification – Time in Range Academy
Master Classes in Diabetes Therapeutics and Technology
Fellowship in Diabetology (F.Diab) – IDF Endorsed
(Also completed: Certificate Course in Evidence-Based Management of Diabetic Retinopathy · Certificate Course in GDM (SAFES) · Certificate in Diabetes & Ramadan (IDF))
M.B.B.S. (Bachelor of Medicine, Bachelor of Surgery)
Awards & Recognition
- Best Research Abstract – Dr. Mohan's International Diabetes Update 2025 (DMIDU 2025), Chennai: "Comparative Evaluation of Claude Pro, LLaMA 4, and Gemini 3: Advanced AI for Clinical Diagnostics and Data Security"
- Best Abstract – ADA Scientific Sessions 2025 (Co-Author): Validation of Mitraa, a GPT-Based Conversational Model for Enhancing Diabetes Self-Management
- Best Abstract – IJDT DTechCon 2025: CGM MAESTRO – A Next-Generation AI Tool for CGM Interpretation and Diabetes Decision-Making
- Winner – Torrent Young Scholar Award 2019 as Best Orator Diabetologist in India
- GOLD Level Global Trainer Faculty – Time in Range Academy, Park Nicollet International Diabetes Center, Minnesota, USA (2022)
- Certified by International Diabetes Federation (IDF) – Diabetes & Ramadan
AI Innovation
Portfolio
CGM Maestro
Winner – Best Abstract, DTechCon 2025.
Mitraa
Winner – Best Abstract, ADA 2025.
DiaShield X
PaperCrafter
JurisMedica
Publications & Research
- 1. Chawla R, Maheshwari A, Modi A, Gupta R, Hirani HA. RSSDI IJDDC position statement on embracing artificial intelligence responsibly in medical research and scientific publication: consensus recommendations for authors, editors, and peer reviewers. Int J Diabetes Dev Ctries. 2026 May. DOI: 10.1007/s13410-026-01559-0
- 3. Samajdar S, Biswas N, Modi A, Joshi S, Hirani HA. Artificial Intelligence, Pharmacokinetic/Pharmacodynamic Modeling, and Digital Twins in Clinical Pharmacology: A Convergence toward Model-informed Precision Dosing. SBV J Basic Clin Appl Health Sci. 2025 Dec.
- 5. Modi A, Kadam P, Saboo B, Kulkarni SV, Hirani HA. Role of Quantum Computing Influencing Artificial Intelligence in Healthcare. Int J Diabetes Technol. 2025 Oct.
- 7. Modi A, Modi A, Saboo B, Kulkarni SV, Hirani HA. The Race of Artificial Intelligence in Healthcare Competition and Its Impact on Human Health. Int J Diabetes Technol. 2025 Aug. DOI: 10.4103/ijdt.ijdt_9_25
-
9. CGM Maestro – Situational CGM Interpretation Tool. Int J Diabetes Technol (IJDT) – DTechCon 2025. 2025.
DTechCon 2025 Best Abstract - 11. PaperCrafter – AI-Assisted Medical Research Writing Tool. Int J Clin Metab Diabetes (IJCMD). 2025.
-
13. Hirani HA, Modi A, Saboo B. Comparative Evaluation of Claude Pro, LLaMA 4, and Gemini 3: Advanced AI for Clinical Diagnostics and Data Security. Dr. Mohan's International Diabetes Update 2025 (DMIDU 2025), Chennai.
DMIDU 2025 Best Research Abstract
- 2. Hirani HA, Shah KI, Tank N, Samajdar SS. Ethical and Legal Implications for the Use of Artificial Intelligence and Telemedicine in Healthcare in India: The Past, Present, and Future Directions. Int J Diabetes Technol. 2026 Apr.
- 4. Hirani H, Saboo B, Modi A, Kadam P. Clinical Assessment of Large Language Models: A Comprehensive Multi-domain Performance Study for Healthcare Applications. Int J Diabetes Technol. 2025 Oct.
- 6. Maheshwari A, Modi A, Hirani H, Saboo B, Samajdar S, Verma N, Tewari A, Gupta A, Dariya SS, Johri R, Kapoor N, Kanodia N. Tropical diabetes or type 5: emerging range of diabetes in tropics. J Diabetes Metab Disord Control. 2025 Aug. DOI: 10.47666/2589-7799.100297
-
8. Saboo B, Saboo S, Hirani HA, Modi AD. 261-OR: Validation of Mitraa, a GPT-Based Conversational Model for Enhancing Diabetes Self-Management and Education. Diabetes. 2025 Jun;74(Suppl 1):261-OR.
ADA 2025 Best Abstract - 10. DiaShield X – Indian Phenotype Diabetes Complication Risk Tool. Int J Diabetes Technol (IJDT) – DTechCon 2025. 2025.
- 12. AI & Rest Strategies for Clinician Wellness Study. Diabetes India 2025 Abstracts (IJDT). 2025.
- 14. Role of Artificial Intelligence in the Management of Metabolic Disorders – The Road Ahead. In: CCDSI Medicine Update 2025 (Chapter 36).
- 16. Emergencies in Peripheral and Cranial Nerve Disorders in Relation to Diabetes. In: API Medicine Update Monograph. Association of Physicians of India; 2020.
- 15. Diabetes and Alzheimer's Disease: The Connection. In: International Textbook of Diabetes: Focus on South Asians. 2021.
International Conference Presentations
- DMIDU 2025, Chennai — Winner Best Research Abstract: "Comparative Evaluation of Claude Pro, LLaMA 4, and Gemini 3: Advanced AI for Clinical Diagnostics and Data Security"
- ADA Scientific Sessions 2025 — Winner Best Abstract (Co-Author): Mitraa GPT-Based Conversational Model for Diabetes Self-Management
- DTechCon 2025 (IJDT) — Winner Best Abstract: CGM Maestro; DiaShield X Presentation
- ATTD-ASIA 2024, Singapore — E-Poster: "Repositioning Low Dose Gliclazide in Uncontrolled Diabetes with Metformin, DPP-4 Inhibitors, and SGLT-2 Inhibitors Using CGM"
Beyond Medicine
Dr. Harsh is a professional drummer, concert director, and music producer — having directed 70+ concerts across India from 2006–2016 as Founder of the Voyagers Band and Director of the Dr. Harsh Ensemble. He is a committed lifelong learner with a passion for international cultural exchange through conference travel, and is an active member of RSSDI, IMA, and BNI.